Federal Register / Vol. 74, No. 196 / Tuesday, October 13, 2009 / Notices 52491 

including any of the following subjects: 

(1) The necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. To obtain copies of 

the supporting statement and any 

related forms for the proposed 

paperwork collections referenced above, 

e-mail your request, including your 

address, phone number, OMB number, 

and OS document identifier, to 

Sherette.funncoleman@hhs.gov, or call 

the Reports Clearance Office on (202) 

690–6162. Written comments and 

recommendations for the proposed 

information collections must be directed 

to the OS Paperwork Clearance Officer 

at the above e-mail address within 60- 

days. 

Proposed Project: The Hospital 

Preparedness Program—Revision-OMB 

No. 0990–0326–OS—Assistant Secretary 

for Preparedness and Response (ASPR). 

Abstract: The Office of the Assistant 

Secretary for Preparedness and 

Response (ASPR), Division of 

Healthcare Preparedness Program (HPP) 

and the State and Local Initiative— 

Program Evaluation Section (SLI-PES), 

is proposing a Web-based reporting 

system to gather critical information and 

data from the 62 Awardees participating 

in the National Bioterrorism Hospital 

Preparedness Program (NBHPP). The 

reporting system will capture 

information related on performance 

measures, critical benchmarks, minimal 

levels of readiness, program statistics, 

policies and procedures, surge capacity 

elements, surge capacity as measured by 

exercises, and other pertinent 

information for programmatic fiscal 

management, improvement and tracking 

performance. The data submitted to HPP 

will be gathered for mid-year reports 

and end of year reports on annual 

activities and progress. 

Awardees will indicate the progress 

made toward each of the financial and 

programmatic objectives noted on their 

cooperative agreement application 

(CAA) on the mid-year progress report. 

The end of year report on annual 

activities will require Awardees to 

provide additional details on objective 

achievement and budget/fiscal 

management. The end of year report 

will also require Awardees to present 

improvements made toward achieving 

the program’s critical benchmarks. 

In addition, the reporting will 

increase ASPR’s ability to quickly and 

efficiently analyze data, identify trends, 

make timely program decisions, and 

provide the Department of Health and 

Human Services (HHS), Congress, and 

other Operating Divisions with data and 

information. 

ESTIMATED ANNUALIZED BURDEN TABLE

Forms 

(if necessary) 

Type of 

respondent 

Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Form is Web-based interface .............................................. Mid-Year 

Report 

62 1 2 124 

Form is Web-based interface .............................................. Final Report 62 1 16 992 

Total .............................................................................. ........................ ........................ ........................ ........................ 1,116 

Seleda Perryman, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. E9–24474 Filed 10–9–09; 8:45 am] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Secretary’s Advisory Committee on 

Human Research Protections 

AGENCY: Office of Public Health and 

Science, Office of the Secretary, 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: Pursuant to Section 10(a) of 

the Federal Advisory Committee Act, 

U.S.C. Appendix 2, notice is hereby 

given that the Secretary’s Advisory 

Committee on Human Research 

Protections (SACHRP) will hold its 

twenty-first meeting. The meeting will 

be open to the public. 

DATES: The meeting will be held on 

Tuesday, October 27, 2009 from 8:30 

a.m. until 5 p.m. and Wednesday, 

October 28, 2009 from 8:30 a.m. until 5 

p.m. 

ADDRESSES: The Sheraton National 

Hotel, 900 South Orme Street, 

Arlington, Virginia 22204. Phone: 703– 

521–1900. 

FOR FUTHER INFORMATION CONTACT: Jerry 

Menikoff, M.D., J.D., Director, Office for 

Human Research Protections (OHRP), or 

Julia Gorey, J.D., Executive Director, 

SACHRP; U.S. Department of Health 

and Human Services, 1101 Wootton 

Parkway, Suite 200, Rockville, 

Maryland 20852; 240–453–8141; fax: 

240–453–6909; e-mail address: 

sachrp@osophs.dhhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

authority of 42 U.S.C. 217a, Section 222 

of the Public Health Service Act, as 

amended, SACHRP was established to 

provide expert advice and 

recommendations to the Secretary of 

Health and Human Services and the 

Assistant Secretary for Health on issues 

and topics pertaining to or associated 

with the protection of human research 

subjects. 

On October 27, 2009, the Committee 

will be briefed on harmonization efforts 

undertaken by the National Institutes of 

Health and discuss possible 

implications for future SACHRP 

committee work. Following this, Dr. 

Marjorie Speers will present and discuss 

the Association for the Accreditation of 

Human Research Protection Programs’ 

recently revised standards for 

accreditation. The day will conclude 

with a report from the Subpart A 

Subcommittee focusing on issues 

surrounding consent for future use of 

specimens or data; this subcommittee is 

charged with developing 

recommendations for consideration by 

SACHRP about the application of 

subpart A of 45 CFR part 46 in the 

current research environment. This 

subcommittee was established by 

SACHRP at its October 4–5, 2006 

meeting. 

On October 28, 2009, SACHRP will 

hear remarks from the Assistant 

Secretary for Health, Dr. Howard Koh. 

This will be followed by a panel 

presentation focusing on types of 

informed consent tools and mechanisms 


erowe on DSK5CLS3C1PROD with NOTICES
52492 Federal Register / Vol. 74, No. 196 / Tuesday, October 13, 2009 / Notices 

that strive to augment the informed 

consent document and increase a 

subject’s understanding of research 

participation. The meeting will 

conclude with a panel of speakers 

focusing on the regulatory barriers that 

may be associated with Community 

Based and Participatory Research. 

Public comment will be heard on both 

days. 

Public attendance at the meeting is 

limited to space available. Individuals 

who plan to attend the meeting and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the designated contact persons. 

Members of the public will have the 

opportunity to provide comments on 

both days of the meeting. Public 

comment will be limited to five minutes 

per speaker. Any members of the public 

who wish to have printed materials 

distributed to SACHRP members for this 

scheduled meeting should submit 

materials to the Executive Director, 

SACHRP, prior to the close of business 

Thursday, October 22, 2009. 

Information about SACHRP and the 

draft meeting agenda will be posted on 

the SACHRP Web site at: http:// 

www.hhs.gov/ohrp/sachrp/index.html. 

Dated: October 6, 2009. 

Jerry Menikoff, 

Director, Office for Human Research 

Protections, Executive Secretary, Secretary’s 

Advisory Committee on Human Research 

Protections. 

[FR Doc. E9–24482 Filed 10–9–09; 8:45 am] 

BILLING CODE 4150–36–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Advisory Committee on 

Blood Safety and Availability 

AGENCY: Department of Health and 

Human Services, Office of the Secretary. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the U.S. 

Department of Health and Human 

Services is hereby giving notice that the 

Advisory Committee on Blood Safety 

and Availability (ACBSA) will hold a 

meeting. The meeting will be open to 

the public. 

DATES: The meeting will take place 

Thursday, November 19 and Friday, 

November 20, 2009 from 8:30 a.m. to 5 

p.m. 

ADDRESSES: The Universities at Shady 

Grove, 9630 Gudelsky Drive, Rockville, 

MD 20850, Phone: 301–738–6000. 

FOR FURTHER INFORMATION CONTACT: Jerry 

A. Holmberg, PhD, Executive Secretary, 

Advisory Committee on Blood Safety 

and Availability, Office of Public Health 

and Science, Department of Health and 

Human Services, 1101 Wootton 

Parkway, Suite 250, Rockville, MD 

20852, (240) 453–8803, FAX (240) 453– 

8456, e-mail ACBSA@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Advisory Committee on Blood Safety 

and Availability provides advice to the 

Secretary and the Assistant Secretary for 

Health on a range of policy issues that 

impact (1) Definition of public health 

parameters around safety and 

availability of the blood supply and 

blood products, (2) broad public health, 

ethical and legal issues related to 

transfusion and transplantation safety, 

and (3) the implications for safety and 

the availability of various economic 

factors affecting product cost and 

supply. 

In keeping with its established 

mission, the ACBSA has been asked to 

review and comment on the current 

processes and parameters which should 

be used in the decision-making process 

for transplantation safety policy. At the 

November 19 and 20, 2009 meeting, the 

Committee will be asked to comment 

and make recommendations on current 

safety decision making processes within 

the Department of Health and Human 

Services while considering those same 

processes within the Private Sector. 

During the meeting, the ACBSA will 

be provided a briefing on Biovigilance 

(surveillance of blood, organs, and 

tissues safety). Specifically, the 

committee will be asked to comment on 

the white paper entitled, ‘‘Biovigilance 

in the United States: Efforts to Bridge a 

Critical Gap in Patient Safety and Donor 

Health.’’ 

The public will have opportunity to 

present their views to the Committee on 

both meeting days. A public comment 

session has been scheduled for 

November 19 and 20, 2009. Comments 

will be limited to five minutes per 

speaker and must be pertinent to the 

discussion. Pre-registration is required 

for participation in the public comment 

session. Any member of the public who 

would like to participate in this session 

is encouraged to contact the Executive 

Secretary at his/her earliest 

convenience. It is requested that those 

who wish to have printed material 

distributed to the Committee provide 

thirty (30) copies of the document to be 

distributed to the Executive Secretary, 

ACBSA, prior to close of business 

November 16, 2009. If it is not possible 

to provide 30 copies of the material to 

be distributed, then individuals are 

requested to provide at a minimum one 

(1) copy of the document(s) to be 

distributed prior to the close of business 

November 16, 2009. It also is requested 

that any member of the public who 

wishes to provide comments to the 

Committee utilizing electronic data 

projection submit the necessary material 

to the Executive Secretary prior to close 

of business November 16, 2009. 

Dated: September 25, 2009. 

Jerry A. Holmberg, 

Executive Secretary, Advisory Committee on 

Blood Safety and Availability. 

[FR Doc. E9–24483 Filed 10–9–09; 8:45 am] 

BILLING CODE 4150–41–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–10–0612] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Maryam Daneshvar, 

CDC Acting Reports Clearance Officer, 

1600 Clifton Road, MS–D74, Atlanta, 

GA 30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Well-Integrated Screening and 

Evaluation for Women Across the 

Nation (WISEWOMAN) Reporting 

System (OMB #0920–0612, exp. 

1/31/2010)—Revision—National Center 


erowe on DSK5CLS3C1PROD with NOTICES